Race and Drug Toxicity: A Study of Three Cardiovascular Drugs with Strong Pharmacogenetic Recommendations
The Clinical Pharmacogenetics Implementation Consortium (CPIC<sup>®</sup>) establishes evidence-based guidelines for utilizing pharmacogenetic information for certain priority drugs. Warfarin, clopidogrel and simvastatin are cardiovascular drugs that carry strong prescribing guidance by...
Guardado en:
Autores principales: | Travis J. O’Brien, Kevin Fenton, Alfateh Sidahmed, April Barbour, Arthur F. Harralson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/995969c752da40b18349b0b3569ab9df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Updating Pharmacogenetic Results: Lessons Learned from the PREDICT Program
por: Michelle Liu, et al.
Publicado: (2021) -
Warfarin drug interaction with vitamin K and other foodstuffs
por: Minighin,Elaine C., et al.
Publicado: (2020) -
Pharmacogenetic Warfarin Dosing Algorithm in the Russian Population
por: T. A. Bairova, et al.
Publicado: (2019) -
Race, Ethnicity, Nativity and Perceptions of Health Risk during the COVID-19 Pandemic in the US
por: Thomas Jamieson, et al.
Publicado: (2021) -
Hebrew, Hebrews, Hubris?: Diagnosing Race and Religion in the Time of COVID-19
por: Richard Newton
Publicado: (2021)